TcBuster™ Gene Transfer System

Cell Engineering

Your Favorite Genes... In Your Favorite Cell^™

B-MoGen is now R&D Systems. Genome Engineering Services from the Same Team with the Same Expertise.

TcBuster^™ is a next-generation non-viral genetic modification system with the potential to deliver therapeutic payloads to various cell types to address a broad range of therapeutic applications.

Along with other non-viral gene therapy platforms, TcBuster has been extensively studied as a tool for intracellular gene transfer for cell and gene therapy. TcBuster can revolutionize your biological research and can provide you with the tool you need to make useful cell lines, produce proteins, vaccines and much more.

TcBuster addresses your challenges with:

the high cost of virus-based genetic modification
the inaccessibility of virus-based modification reagents
the cargo size constraints of virus-based systems

Let us help you create novel cell lines to address your unique applications.

Solve Your Gene Transfer Problems with TcBuster

TcBuster is a transposon-based technology used to deliver your gene-of-interest safely and randomly into a host’s genome. Watch how TcBuster can help you achieve your genome engineering goals.

Explore Our Other Services

Cellular and Genome Engineering Services

GMP Cell Manufacturing and Process Development

TcBuster^™ - Non-Viral Transgene Insertion

TcBuster is a core technology in our methods and research. Transposons have demonstrated the safest insertion profile of any gene delivery system while maintaining high efficiency gene transfer and enable us to rapidly generate transgenic mammalian cells with limited off-target effects and stable, reliable gene expression.

Advantages of Non-Viral Delivery

Our high efficiency non-viral TcBuster^™ system enables therapeutic companies to reduce costs, ensure supply chain stability, and produce safer products.

Non-viral delivery in contrast to lentivirus gene delivery:

lower cost per patient.
does not provoke an immune response.
does not carry mutagenic risks.
shows few preferences for integration sites.

	Lentivirus	TcBuster^™
Cost	+++	+
Consistency	Lot-to-lot variability Supply shortages	Scalable Repeatable
Capacity	Limited size of cargo >Max 9kb	Demonstrated ability to transfer multiple genes >11kb
Safety	Random integration; Preference for: - exons - transcriptional start sites	Random integration; No preference
Mediates stable gene transfer	Yes	Yes
Used clinically	+++	++
Immunogenicity	Yes	No

Overcome Limits of Electroporation

Our cutting edge non-viral vector transgene insertion platform harnesses DNA transposons for stable gene transfer into any cell type. TcBuster overcomes the three major technical challenges of other transposon systems.

Insertion efficiency - greater than 40% insertion efficiency for stable integration in T cells
DNA toxicity - proprietary techniques reduce effects of DNA toxicity
Integration of enzyme DNA into host genome - delivery of transposase as mRNA or protein.

DNA transposons are a core technology in our methods and research. Transposons have demonstrated the safest insertion profile of any gene delivery system while maintaining high efficiency gene transfer. DNA transposons enable rapid generation of transgenic mammalian cells with limited off-target effects and stable, reliable gene expression.

Transposons: How Do We Compare?

	Sleeping Beauty^™	piggyBac^™	TcBuster^™
Source	Salmonid fossils	Cabbage Looper	Red Flour Beetle
Provider	Ziopharm/Merck	Transpoagen/Posieda	R&D Systems
Performance	In the clinic	In the clinic	40% Transposition efficiency
Availability	Unavailable (Exclusively Licensed)	Unavailable (Exclusively Licensed)	Available